Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, in partnership with Hitachi High-Tech ...

The appeal of these diverse careers often lies in the different types of impact they enable. A PhD can teach more than ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

The nation’s leading doctors groups are in a standoff with federal health officials over vaccines. The conflict intensified ...

Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...

At any one time, nearly 1 in 5 emergency department patients in the UK is being cared for in corridors, waiting rooms, and other non-standard ‘overflow’ spaces—an approach known as escalation area ...

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

Meghan Markle and Prince Harry have received a good news about their royal titles amid claims Prince William will strip them of their honours when he becomes the King. The good news has come from ...

SE Ranking analyzed 129,000 domains to identify the top 20 factors driving ChatGPT citations. Backlinks, traffic, and trust scores ranked highest. Solid SEO fundamentals still align with higher ...

What are the two mystery Special Presentations being planned by Marvel Studios? Head to to save 10% off your first purchase of a website or domain using code NEWROCKSTARS. Could Marvel Studios be ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

CINCINNATI--(BUSINESS WIRE)--LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company advancing Lerodalcibep (Lerochol®), a novel, monthly, small dose third-generation PCSK9 ...